NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank40
3Y CAGR-15.9%
5Y CAGR-0.1%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-15.9%/yr
Annual compound
5Y CAGR
-0.1%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineFair Value
PeriodValueYoY Change
20257.88-2.5%
20248.08+16.2%
20236.95-47.6%
202213.26+122.5%
20215.96-24.6%
20207.90-